Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
397.50    2.00 (0.51%)
Bid:
390.00
Ask:
405.00
Spread: 15.00 (3.846%)
Market Cap: £190.07m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Director Appointment

5 Feb 2019 07:00

RNS Number : 0430P
Tristel PLC
05 February 2019
 

Tristel plc

("Tristel" or the "Company")

 

Director Appointment

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention and contamination control products utilising proprietary chlorine dioxide chemistry, announces the appointment of Dr. Bruno Holthof to its Board as a non-executive director.

 

Dr. Bruno Holthof is the Chief Executive Officer of Oxford University Hospitals ("OUH"). Before OUH, he was CEO of the Antwerp Hospital Network from January 2004 until September 2015. Bruno Holthof is also Chair of the Board of Armonea, a European private care home provider.

 

Before becoming a CEO, he was a partner at McKinsey & Company. During this period, he served a wide range of healthcare clients in Europe and the United States and gained significant expertise in the areas of strategy, organisation and operations. He holds an MBA from the Harvard Business School and an MD/PhD from the University of Leuven.

 

Commenting on the appointment, Paul Swinney, CEO of Tristel, said: "We are delighted to welcome Bruno to our Board. Bruno has more than 10 years of board level experience on publicly listed companies. He also brings to the Board an in-depth knowledge and operational experience of healthcare systems in different markets. We very much look forward to working together."

 

 

For further information please contact:

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Finance Director

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

finnCap

Tel: 020 7220 0500

Geoff Nash/ Giles Rolls (Corporate Finance)

Alice Lane (Corporate Broking)

 

 

Regulatory disclosure - The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

Bruno Luc Myriam Holthof, 57, holds nil ordinary shares in the Company and nil options. Dr. Holthof current and previous directorships are as follows:

 

Current Directorships/Partnerships:

 

Project Tower Member 2 Limited

Praksis UK Ltd

Shelford Health Roundtable

Oxford University Hospital NHS Foundation Trust

Armonea Group NV

 

Directorship held in last 5 years:

 

Barco NV

BPost NV/SA

 

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUSSKRKBAURAR
Date   Source Headline
23rd Nov 201612:37 pmRNSIssue of Equity
17th Oct 20167:00 amRNSFinal Results
13th Oct 20168:33 amRNSIssue of Equity
12th Oct 20168:12 amRNSStudy shows Tristel Wipes System benefits
11th Oct 20167:00 amRNSStudy shows Tristel Wipes System benefits
20th Sep 20167:00 amRNSNotice of Results
19th Sep 20169:24 amRNSIssue of Equity
12th Sep 20167:00 amRNSRegulatory approval in Australia for surface range
19th Aug 20164:30 pmRNSDirector/PDMR Shareholding
19th Aug 20161:30 pmRNSIssue of Equity
21st Jul 20163:26 pmRNSDirector Dealing
21st Jul 20167:00 amRNSTrading update, Special dividend & Acquisition
25th May 20167:00 amRNSShareholder Open Day & Notice of Trading Update
29th Apr 201611:06 amRNSDirector Dealing
26th Apr 201610:06 amRNSDirector Dealing
15th Mar 20167:00 amRNSDirector Dealing
11th Mar 20167:00 amRNSDirector Dealing
10th Mar 20167:00 amRNSDirector Dealing
2nd Mar 20165:13 pmRNSDirector Dealing
2nd Mar 20169:46 amRNSDirector Dealing
29th Feb 20167:00 amRNSDirector Dealing
26th Feb 20169:43 amRNSDirectors Dealings
24th Feb 20167:00 amRNSHalf Yearly Report
25th Jan 20167:00 amRNSNotice of Results
13th Jan 20164:53 pmRNSIssue of Equity
5th Jan 20167:00 amRNSTransition of German branch to subsidiary status
15th Dec 20151:43 pmRNSDirectors Dealings
15th Dec 201512:18 pmRNSResult of AGM
15th Dec 20157:00 amRNSAGM Statement
2nd Dec 201511:37 amRNSIssue of Equity
1st Dec 201511:06 amRNSPosting of Annual Report & Notice of AGM
1st Dec 201511:05 amRNSFrench study shows superiority of Tristel Wipes
2nd Nov 20153:42 pmRNSIssue of Equity
22nd Oct 20154:02 pmRNSIssue of Equity
15th Oct 20159:50 amRNSIssue of Equity/Director Dealing
12th Oct 20157:00 amRNSFinal Results
5th Oct 20157:00 amRNSInvestor results briefing - Change of venue
1st Oct 20157:00 amRNSAppointment of Non-Executive Director
25th Sep 20151:52 pmRNSIssue of Equity
18th Sep 20157:00 amRNSNotice of Results
18th Aug 201510:14 amRNSIssue of Equity
17th Aug 20151:07 pmRNSDirector Share Transfer
6th Aug 201511:01 amRNSIssue of Equity
4th Aug 201511:57 amRNSDirectors dealing/grant of options
20th Jul 20154:25 pmRNSIssue of Equity
30th Jun 20154:59 pmRNSIssue of Equity
24th Jun 20154:08 pmRNSIssue of Equity
23rd Jun 20153:15 pmRNSIssue of Equity
18th Jun 20159:00 amRNSDirector Dealing/Issue of Equity
18th Jun 20157:00 amRNSSpecial Dividend and notice of results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.